A review: FDA-approved fluorine-containing small molecules from 2015 to 2022
N Sheikhi, M Bahraminejad, M Saeedi… - European Journal of …, 2023 - Elsevier
Fluorine-containing small molecules have occupied an especial position in drug discovery
research. The successful clinical use of fluorinated corticosteroids in the 1950s and …
research. The successful clinical use of fluorinated corticosteroids in the 1950s and …
Application of next generation sequencing for diagnosis and clinical management of drug-resistant tuberculosis: updates on recent developments in the field
N Dookie, A Khan, N Padayatchi, K Naidoo - Frontiers in Microbiology, 2022 - frontiersin.org
The World Health Organization's End TB Strategy prioritizes universal access to an early
diagnosis and comprehensive drug susceptibility testing (DST) for all individuals with …
diagnosis and comprehensive drug susceptibility testing (DST) for all individuals with …
Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid
A Bateson, J Ortiz Canseco, TD McHugh… - Journal of …, 2022 - academic.oup.com
Objectives To develop a robust phenotypic antimicrobial susceptibility testing (AST) method
with a correctly set breakpoint for pretomanid (Pa), the most recently approved anti …
with a correctly set breakpoint for pretomanid (Pa), the most recently approved anti …
[BOOK][B] Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance
World Health Organization - 2023 - books.google.com
Page 1 Catalogue of mutations in Mycobacterium tuberculosis complex and their
association with drug resistance Second edition Page 2 Page 3 Catalogue of mutations in …
association with drug resistance Second edition Page 2 Page 3 Catalogue of mutations in …
Genetic diversity of candidate loci linked to Mycobacterium tuberculosis resistance to bedaquiline, delamanid and pretomanid
Tuberculosis (TB), caused by Mycobacterium tuberculosis, is one of the deadliest infectious
diseases worldwide. Multidrug and extensively drug-resistant strains are making disease …
diseases worldwide. Multidrug and extensively drug-resistant strains are making disease …
Profiling pretomanid as a therapeutic option for TB infection: evidence to date
SL Stancil, F Mirzayev… - Drug Design …, 2021 - Taylor & Francis
Tuberculosis (TB) is the most deadly infectious disease globally. Although most individuals
achieve a cure, a substantial portion develop multi-drug resistant TB which is exceedingly …
achieve a cure, a substantial portion develop multi-drug resistant TB which is exceedingly …
Delamanid or pretomanid? A Solomonic judgement!
SE Mudde, AM Upton, A Lenaerts, HI Bax… - Journal of …, 2022 - academic.oup.com
Given the low treatment success rates of drug-resistant tuberculosis (TB), novel TB drugs are
urgently needed. The landscape of TB treatment has changed considerably over the last …
urgently needed. The landscape of TB treatment has changed considerably over the last …
Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid
J Timm, A Bateson, P Solanki, A Paleckyte… - PLOS Global Public …, 2023 - journals.plos.org
Bedaquiline (B), pretomanid (Pa) and linezolid (L) are key components of new regimens for
treating rifampicin-resistant tuberculosis (TB). However, there is limited information on the …
treating rifampicin-resistant tuberculosis (TB). However, there is limited information on the …
Fabrication of MoS2/Bi2S3 heterostructure for photocatalytic degradation of Metronidazole and Cefalexin and antibacterial applications under NIR light …
In this research, molybdenum disulfide (MoS2) and bismuth trisulfide (Bi2S3) particles were
synthesized. Bi2S3 was loaded on MoS2 nanosheet and was characterized by several …
synthesized. Bi2S3 was loaded on MoS2 nanosheet and was characterized by several …
[PDF][PDF] Optimized broth microdilution plate methodology for drug susceptibility testing of Mycobacterium tuberculosis complex
World Health Organization - 2022 - apps.who.int
Under the terms of this licence, you may copy, redistribute and adapt the work for non-
commercial purposes, provided the work is appropriately cited, as indicated below. In any …
commercial purposes, provided the work is appropriately cited, as indicated below. In any …